Kirova et al. found no difference (P = 0.13) in IBTR when they compared 27 BRCA1/2 mutation carriers to 104 patients with a family history of breast cancer to 261 matched controls with a 13.4 year followup [20]. The gene discussed is BRCA1; the disease is breast cancer.